Înapoi la știri

Exclusive | Netflix exec goes ballistic after being fired for stunning 'trust exercise' confession at retreat: suit - New York Post

37 minute în urmă
6 minute min
Maria Simionescu
See more of our coverage in your search results. Add The California Post on Google A Netflix executive was fired from his $1.1 million a year job after revealing during a “trust exercise” at a work retreat that he had taken medically prescribed ketamine, a lawsuit has claimed. Kevin Baillie, who was vice president and head of creative at Eyeline Studios, is suing the company after it launched an investigation into his comments that ultimately ended in his firing, the papers say.  Baillie, who’s been on the visual effects team for “Pirates of the Caribbean” and the Harry Potter franchise, says he took the drug under medical supervision in October and November of 2022 at a Santa Barbara clinic. He sought the treatment for clinical depression after the death of his mother, according to the suit. During what’s called a “Vulnerability-Trust exercise” at a January 2026 retreat at the exclusive Sendero Ranch, a Northern California property owned by Netflix, Baillie shared with his colleagues that he had undergone the treatment, the suit says. Baillie claims he explained the reason why he had taken the drug but was investigated by Netflix. On March 18, 2026 a company investigator brought the incident up, “in a manner suggesting suspicion of recreational drug use,” the suit reads. The executive was fired in April with the company’s attorney confirming “the ketamine therapy issue has factored into the termination,” the papers say, and go on to suggest Baille was denied up to a year of severance pay. Baillie says in the lawsuit the “scope” of the investigation related to alleged profanity and drinking. He had been warned during his performance review that he should “drop one or two less f-bombs but don’t stop entirely.” It goes on to say that at the same retreat Baillie drank a Guinness standing on his head, after sharing that he had learned the trick from his former father in law during a conversation inspired by the trust session. “His colleague immediately asked for a demonstration, rather than withhold the openness that the session had encouraged, he performed the trick,” the papers say. Baille also paints a picture of an allegedly alcohol-fueled company environment encouraged by the Eyeline Studios CEO Jeff Shapiro. The lawsuit alleged “alcohol consumption was company-sponsored, leadership-modeled and condoned”, with multiple examples of how Shapiro “set the cultural tone concerning alcohol at the executive level”. The documents claimed Shapiro on one occasion purchased beer at a corner store and brought it to a company car ride to the Visual Effects Society Awards for staff to share. Baillie claims he also witnessed the CEO consume alcohol with Netflix and Eyeline employees at his own welcome dinner in September 2024, the Netflix Annual Business Review events in March 2025 and even a Lakers game attended by Netflix execs including Shapiro’s direct supervisor in February 2026. All up, Baillie’s attorneys provided over half a dozen examples of the CEO being present at a work event with a drink in his hand, according to court papers. California Post News: Facebook, Instagram, TikTok, X, YouTube, WhatsApp, LinkedInCalifornia Post Sports Facebook, Instagram, TikTok, YouTube, XCalifornia Post Opinion California Post Newsletters: Sign up here!California Post App: Download here!Home delivery: Sign up here!Page Six Hollywood: Sign up here! In addition to hosting multiple parties, Shapiro also had a personal bar in his office “from which he served alcohol (to Baille) including after a successful meeting with Netflix’s CEO Ted Sarandos,” according to the papers. Baillie is asking for a jury trial, compensatory damages, lost wages, damages for emotional distress, and punitive damages. Netflix and Eyeline were contacted for comment.
Alte postari din Economie
Economie

Making sense of the panic over Chinese AI - TechCrunch

The launch of the latest AI model from a Chinese company — Moonshot AI’s Kimi — reignited debates around American competitiveness and open versus proprietary AI. While there was plenty of conversation on social media, it seems the debate is also happening behind the scenes in Washington, D.C., where OpenAI and Anthropic have reportedly lobbied regulators with concern about open Chinese models.

Economie

Two pain drugs used by millions will be combined in a single tablet - USA Today

Hide Caption #videoDetailsToggle{color:var( --color-dove-gray,rgba(0,0,0,.6));cursor:pointer;display:inline-block;font-family:var(--sans-serif,sans-serif);font-size:var(--type-7);font-weight:var( --font-weight-bold,900);line-height:var(--spacer-twentyfour,24px);margin-bottom:-8px}#vdt_hide{margin-bottom:10px}.vdt-flex{display:none}.vdt-svg{fill:var( --color-dove-gray,rgba(0,0,0,.6));height:var(--spacer-twentyfour,24px);width:var(--spacer-twentyfour,24px)} (function() { let vdContainer, vdShow, vdHide, flagCaption = false, vdToggle = document.getElementById('videoDetailsToggle'), section = ga_data.route.sectionName || ga_data.route.ssts.split('/'), subsection = ga_data.route.ssts.split('/'); vdToggle.addEventListener('click', ()=> { // query dom only after user click if (!vdContainer) { vdContainer = document.getElementById('videoDetailsContainer'); vdShow = document.getElementById('vdt_show'), vdHide = document.getElementById('vdt_hide'); } vdContainer.hidden = !(vdContainer.hidden); // show/hide elements if (vdContainer.hidden) { vdShow.hidden = false; vdHide.hidden = true; } else { if (!flagCaption) { flagCaption = true; fireCaptionAnalytics() } vdShow.hidden = true; vdHide.hidden = false; } }); function fireCaptionAnalytics () { let analytics = document.getElementById("pageAnalytics"); try { if (analytics) { analytics.fireEvent(`${ga_data.route.basePageType}|${section}|${subsection}|streamline|expandCaption`); } else { if (window.newrelic) window.newrelic.noticeError('page analytics tag not found'); } } catch (e) { if (window.newrelic) window.newrelic.noticeError(e); } } }()); Texas sues makers of Tylenol over alleged link to autismThe Texas Attorney General Ken Paxton is suing the makers of Tylenol, alleging it failed to warn consumers about risks of the drug.Consumers will soon have a new over-the-counter pain relief option that combines Tylenol with naproxen, an anti-inflammatory medication. The Food and Drug Administration on July 24 approved the non-prescription combination dosage of 650 mg of Tylenol (acetaminophen) and 220 mg of naproxen sodium.

Economie

US regulators to weigh controversial peptides backed by RFK Jr - Al Jazeera

The US Food and Drug Administration has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing. xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoUS Secretary of Health and Human Services Robert F Kennedy Jr listens during a May 27 Cabinet meeting at the White House, in Washington, DC, the United States By Al Jazeera Staff, Reuters and The Associated PressPublished On 22 Jul 202622 Jul 2026Peptides, a class of compounds increasingly marketed as wellness treatments, have exploded in popularity in recent years, moving from niche bodybuilding and biohacking circles to now being promoted for everything from weight loss to longevity.

Acasa Recente Radio Județe